Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.
about
Adjuvant Gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal womenGnRH agonist therapy to protect ovarian function in young Korean breast cancer patientsTamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.Fertility preservation in breast cancer patients.Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: a population-based cohort studyCounting the costs of treatment: the reproductive and gynaecological consequences of adjuvant therapy in young women with breast cancer.Fertility and outcomes of pregnancy after chemotherapy in a sample of childbearing aged women.Fertility preservation in reproductive-age women facing gonadotoxic treatments.Applicability of adult techniques for ovarian preservation to childhood cancer patients.Fertility preservation in female oncology patients.Fertility preservation in female cancer survivors.Ovarian recovery after stem cell transplantation.Characterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary.Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure.Reproductive health issues in women with cancer.Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females.Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide.GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?Sphingosine-1-phosphate activates the AKT pathway to inhibit chemotherapy induced human granulosa cell apoptosis.Fertility status among women treated for aggressive non-Hodgkin's lymphoma.Female Fertility Preservation, Clinical and Experimental OptionsIntravenous Infusion of Nucleated Peripheral Blood Cells Restores Fertility in Mice with Chemotherapy-Induced Premature Ovarian Failure
P2860
Q24241143-5E5D0152-B269-42ED-AE4B-A238B30C0936Q33565544-3B207438-6213-4D02-ADC0-D4DFB05E1DE7Q34370266-0BFB34EA-4855-46C0-8088-428DFF858526Q34410874-EC32FC37-90EF-41B4-8C32-EC0C4034C35AQ34653591-7D063A43-FA19-4F58-B769-3A2D5D345703Q35190628-8FCEFAF4-A7CE-4C09-8C68-036B6E334F8EQ35917623-9AE023ED-4E31-41B1-A54D-666CC4445D82Q35934317-83F4E2D7-04C1-4452-962B-4AC5D2335D50Q36295588-46BA9131-E10E-46EF-B920-688946AF8EDCQ36379541-45CA58A6-B079-4799-89A4-5965297ACB4CQ36892421-E96D42C7-05FD-40BF-8867-B6EC72F661ABQ36977555-C7D740AF-83BC-4AF2-9FB9-A4D53844E474Q37181877-2D0C6327-B9E9-4230-99CE-31FEA5C5A4E6Q37372147-C0B58A60-4C96-47D1-9E2B-20B365504D2EQ37477020-0BAA9914-81D7-4C44-A976-6A652879D888Q42511622-3C450ADE-3F75-46D0-AF2E-670FAC30478DQ42513850-262D7237-46DE-4115-A072-74AE985FCF4EQ47886578-A65CF687-4739-43A3-A153-4ACDC8F1C97DQ48572207-6FB7B85B-CFF9-45AA-8B52-BDDA1C2D25DDQ50604899-CB44D5F4-DDE1-4175-9026-9AC4EEE19A01Q51104639-9E377389-23A3-48E3-A25F-AAF4A82B4007Q51805746-7F3266AF-6412-4740-A7CE-82A4EE748635Q57091935-06DC92DB-AAC3-472A-B33D-8592BD5809B5Q58736904-F0C4B536-E0DA-4D16-B4A3-F416663E8225
P2860
Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Preservation of fertility and ...... gonadotoxicity in young women.
@ast
Preservation of fertility and ...... gonadotoxicity in young women.
@en
type
label
Preservation of fertility and ...... gonadotoxicity in young women.
@ast
Preservation of fertility and ...... gonadotoxicity in young women.
@en
prefLabel
Preservation of fertility and ...... gonadotoxicity in young women.
@ast
Preservation of fertility and ...... gonadotoxicity in young women.
@en
P2093
P1476
Preservation of fertility and ...... gonadotoxicity in young women.
@en
P2093
P304
P356
10.1016/S1071-5576(99)00028-3
P577
1999-09-01T00:00:00Z